Still on very undemanding valuation and looking very...

  1. 335 Posts.
    lightbulb Created with Sketch. 66
    Still on very undemanding valuation and looking very well-positioned for growth with the move to favour on onshore suppliers to avoid shipping issues.
    Not to mention likely resumption of sales with the spread of Omicron - assuming there'll be a strong demand for medicines which treat the cold/flu like symptoms.
    Thoughts?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.